Atika Capital Management LLC Argenx Se Transaction History

Atika Capital Management LLC

$867 Million
Q1 2024

A detailed history of Atika Capital Management LLC transactions in Argenx Se stock. As of the latest transaction made, Atika Capital Management LLC holds 26,695 shares of ARGX stock, worth $11.5 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

26,695

Previous 26,695 -0.0%

Holding current value

$11.5 Million

Previous $10.2 Million 3.5%

% of portfolio

1.21%

Previous 1.51%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $677,820 - $1.01 Million	2,000 Added 8.1%	26,695 $10.2 Million
Q1 2023 May 12, 2023	SELL	$334.23 - $403.65 $944,533 - $1.14 Million	-2,826 Reduced 10.27%	24,695 $9.2 Million
Q4 2022 Feb 13, 2023	SELL	$342.17 - $402.31 $2.9 Million - $3.41 Million	-8,479 Reduced 23.55%	27,521 $10.4 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $1.37 Million - $1.58 Million	4,000 Added 12.5%	36,000 $12.7 Million
Q2 2022 Aug 12, 2022	BUY	$269.58 - $378.88 $1.11 Million - $1.55 Million	4,100 Added 14.7%	32,000 $12.1 Million

Q1 2022 May 13, 2022	SELL	$254.45 - $351.06 $2.8 Million - $3.86 Million	-11,000 Reduced 28.28%	27,900 $8.8 Million
Q4 2021 Feb 11, 2022	SELL	$272.01 - $353.03 $598,422 - $776,665	-2,200 Reduced 5.35%	38,900 $13.6 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $295,000 - $350,580	1,000 Added 2.49%	41,100 $12.4 Million
Q2 2021 Aug 12, 2021	SELL	$257.11 - $319.92 $257,110 - $319,920	-1,000 Reduced 2.43%	40,100 $12.1 Million
Q1 2021 May 14, 2021	SELL	$268.3 - $380.31 $1.69 Million - $2.4 Million	-6,300 Reduced 13.29%	41,100 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $645,138 - $801,736	2,600 Added 5.8%	47,400 $13.9 Million
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $711,183 - $899,283	3,300 Added 7.95%	44,800 $11.8 Million
Q2 2020 Aug 13, 2020	SELL	$127.44 - $232.72 $955,800 - $1.75 Million	-7,500 Reduced 15.31%	41,500 $9.35 Million
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $457,086 - $693,966	4,200 Added 9.38%	49,000 $6.46 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $328,599 - $436,479	2,900 Added 6.92%	44,800 $5.11 Million
Q2 2019 Aug 12, 2019	SELL	$115.0 - $141.58 $1.15 Million - $1.42 Million	-10,000 Reduced 19.27%	41,900 $5.93 Million
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $748,491 - $1.29 Million	-11,730 Reduced 18.43%	51,900 $4.99 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $273,310 - $349,800	3,620 Added 6.03%	63,630 $4.83 Million
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $1.72 Million - $2.3 Million	23,010 Added 62.19%	60,010 $4.97 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $2.11 Million - $3.15 Million	37,000 New	37,000 $2.98 Million

Others Institutions Holding ARGX

# of Institutions

356

Shares Held

31.3M

Call Options Held

212K

Put Options Held

210K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $23.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account

Atika Capital Management LLC Argenx Se Transaction History